Free Trial
NASDAQ:CDLX

Cardlytics (CDLX) Stock Price, News & Analysis

Cardlytics logo
$3.71 +0.16 (+4.51%)
(As of 12/20/2024 05:31 PM ET)

About Cardlytics Stock (NASDAQ:CDLX)

Key Stats

Today's Range
$3.44
$3.72
50-Day Range
$3.38
$5.21
52-Week Range
$2.89
$20.52
Volume
981,965 shs
Average Volume
1.18 million shs
Market Capitalization
$188.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.92
Consensus Rating
Hold

Company Overview

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.

Cardlytics Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
64th Percentile Overall Score

CDLX MarketRank™: 

Cardlytics scored higher than 64% of companies evaluated by MarketBeat, and ranked 128th out of 333 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cardlytics has received a consensus rating of Hold. The company's average rating score is 2.14, and is based on no buy ratings, 5 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Cardlytics has only been the subject of 3 research reports in the past 90 days.

  • Read more about Cardlytics' stock forecast and price target.
  • Earnings Growth

    Earnings for Cardlytics are expected to decrease in the coming year, from ($1.52) to ($1.70) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cardlytics is -0.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cardlytics is -0.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Cardlytics has a P/B Ratio of 1.08. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    13.77% of the outstanding shares of Cardlytics have been sold short.
  • Short Interest Ratio / Days to Cover

    Cardlytics has a short interest ratio ("days to cover") of 9.3.
  • Change versus previous month

    Short interest in Cardlytics has recently decreased by 2.64%, indicating that investor sentiment is improving.
  • Dividend Yield

    Cardlytics does not currently pay a dividend.

  • Dividend Growth

    Cardlytics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    13.77% of the outstanding shares of Cardlytics have been sold short.
  • Short Interest Ratio / Days to Cover

    Cardlytics has a short interest ratio ("days to cover") of 9.3.
  • Change versus previous month

    Short interest in Cardlytics has recently decreased by 2.64%, indicating that investor sentiment is improving.
  • News Sentiment

    Cardlytics has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Business Services companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Cardlytics this week, compared to 4 articles on an average week.
  • MarketBeat Follows

    Only 1 people have added Cardlytics to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cardlytics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $237,767.00 in company stock.

  • Percentage Held by Insiders

    Only 4.40% of the stock of Cardlytics is held by insiders.

  • Percentage Held by Institutions

    68.10% of the stock of Cardlytics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Cardlytics' insider trading history.
Receive CDLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardlytics and its competitors with MarketBeat's FREE daily newsletter.

CDLX Stock News Headlines

Northland Securities Keeps Their Hold Rating on Cardlytics (CDLX)
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
See More Headlines

CDLX Stock Analysis - Frequently Asked Questions

Cardlytics' stock was trading at $9.21 at the beginning of the year. Since then, CDLX shares have decreased by 59.7% and is now trading at $3.71.
View the best growth stocks for 2024 here
.

Cardlytics, Inc. (NASDAQ:CDLX) released its quarterly earnings data on Wednesday, November, 6th. The company reported ($0.15) EPS for the quarter, beating analysts' consensus estimates of ($0.33) by $0.18. The company's revenue was down 15.1% compared to the same quarter last year.

The following companies are subsidiaries of Cardlytics: Bridg, DOSH, Cardlytics Services India Private Limited, and Cardlytics UK Limited.

Cardlytics (CDLX) raised $76 million in an initial public offering (IPO) on Friday, February 9th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

Top institutional shareholders of Cardlytics include Geode Capital Management LLC (2.07%), State Street Corp (1.72%), Baillie Gifford & Co. (1.14%) and RBF Capital LLC (0.96%). Insiders that own company stock include Clifford Sosin, Karim Saad Temsamani, Lynne Marie Laube, Scott D Grimes, Amit Gupta, Alexis Desieno, Nicholas Hollmeyer Lynton, Andrew Christiansen, John V Balen and Kirk Somers.
View institutional ownership trends
.

Shares of CDLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardlytics investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), Intel (INTC) and Rambus (RMBS).

Company Calendar

Last Earnings
11/06/2024
Today
12/21/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Computer programming, data processing, & other computer related
Sub-Industry
Computer Software
Current Symbol
NASDAQ:CDLX
Fax
N/A
Employees
457
Year Founded
2008

Price Target and Rating

Average Stock Price Target
$6.92
High Stock Price Target
$12.00
Low Stock Price Target
$3.50
Potential Upside/Downside
+86.4%
Consensus Rating
Hold
Rating Score (0-4)
2.14
Research Coverage
7 Analysts

Profitability

Net Income
$-134,700,000.00
Pretax Margin
-93.55%

Debt

Sales & Book Value

Annual Sales
$293.47 million
Cash Flow
$1.19 per share
Book Value
$3.43 per share

Miscellaneous

Free Float
48,586,000
Market Cap
$188.55 million
Optionable
Optionable
Beta
1.53

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

This page (NASDAQ:CDLX) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners